UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046923
Receipt number R000053535
Scientific Title Study on life and physical prognosis of hospitalized patients with aspiration pneumonia
Date of disclosure of the study information 2022/02/17
Last modified on 2022/08/19 16:37:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on life and physical prognosis of hospitalized patients with aspiration pneumonia

Acronym

Study on life and physical prognosis of hospitalized patients with aspiration pneumonia

Scientific Title

Study on life and physical prognosis of hospitalized patients with aspiration pneumonia

Scientific Title:Acronym

Study on life and physical prognosis of hospitalized patients with aspiration pneumonia

Region

Japan


Condition

Condition

aspiration pneumonia

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the life and physical prognosis of patients with aspiration pneumonia

Basic objectives2

Others

Basic objectives -Others

Explain for factors that influence life and physical prognosis

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

90-day survival

Key secondary outcomes

ability to walk


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

All cases

Key exclusion criteria

None

Target sample size

330


Research contact person

Name of lead principal investigator

1st name Yorihide
Middle name
Last name Yanagita

Organization

Seirei Mikatahara General Hospital

Division name

Department of Rehabilitation Medicine

Zip code

4338558

Address

3453, Mikatahara-cho, Hamamatsu City, Shizuoka Prefecture

TEL

053-436-1251

Email

dependonhero@yahoo.co.jp


Public contact

Name of contact person

1st name Yorihide
Middle name
Last name Yanagita

Organization

Seirei Mikatahara General Hospital

Division name

Department of Rehabilitation Medicine

Zip code

4338558

Address

3453, Mikatahara-cho, Hamamatsu City, Shizuoka Prefecture

TEL

053-436-1251

Homepage URL


Email

dependonhero@yahoo.co.jp


Sponsor or person

Institute

Seirei Mikatahara General Hospital, Department of Rehabilitation Medicine

Institute

Department

Personal name



Funding Source

Organization

Seirei Mikatahara General Hospital, Department of Rehabilitation Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Seirei Mikatahara General Hospital

Address

3453, Mikatahara-cho, Hamamatsu City, Shizuoka Prefecture

Tel

053-436-1251

Email

dependonhero@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 17 Day


Related information

URL releasing protocol

https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902237347483549

Publication of results

Unpublished


Result

URL related to results and publications

https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902237347483549

Number of participants that the trial has enrolled

333

Results

In total, 333 consecutive patients with aspiration pneumonitis were screened for eligibility, of whom 276 (82.9%) were recruited for the study.
There were 231 survivors and 45 non-survivors. There were significant differences in 11 items in the comparison between the two groups.
Multivariate logistic regression model results showed that A-DROP score, GNRI score, and gender were independent early predictors of mortality.

Results date posted

2022 Year 02 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients admitted to hospital with swallowing pneumonia

Participant flow

Patients were included in the study by being hospitalized. At Seirei Mikatahara General Hospital, we explained the unintended use of medical records at the time of the first visit using oral and written information. In this study, we only included patients in which informed consent was obtained for the unintended use of medical records.

Adverse events

None

Outcome measures

90-day survival

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 02 Month 01 Day

Date of IRB

2017 Year 12 Month 15 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 01 Month 01 Day

Date trial data considered complete

2018 Year 01 Month 01 Day

Date analysis concluded

2022 Year 07 Month 06 Day


Other

Other related information

Patient information of all patients hospitalized with aspiration pneumonia over a 1-year period was analyzed.


Management information

Registered date

2022 Year 02 Month 16 Day

Last modified on

2022 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053535